Profound Medical (PROF) Competitors $4.54 -0.15 (-3.20%) Closing price 04/8/2025 03:59 PM EasternExtended Trading$4.18 -0.36 (-7.91%) As of 04/8/2025 07:19 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PROF vs. CBLL, IRMD, AVNS, KIDS, SIBN, BFLY, BBNX, TMCI, DCTH, and NPCEShould you be buying Profound Medical stock or one of its competitors? The main competitors of Profound Medical include CeriBell (CBLL), Iradimed (IRMD), Avanos Medical (AVNS), OrthoPediatrics (KIDS), SI-BONE (SIBN), Butterfly Network (BFLY), Beta Bionics (BBNX), Treace Medical Concepts (TMCI), Delcath Systems (DCTH), and NeuroPace (NPCE). These companies are all part of the "medical equipment" industry. Profound Medical vs. CeriBell Iradimed Avanos Medical OrthoPediatrics SI-BONE Butterfly Network Beta Bionics Treace Medical Concepts Delcath Systems NeuroPace Profound Medical (NASDAQ:PROF) and CeriBell (NASDAQ:CBLL) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, profitability, analyst recommendations, community ranking, earnings, valuation, risk and media sentiment. Which has better earnings and valuation, PROF or CBLL? CeriBell has higher revenue and earnings than Profound Medical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioProfound Medical$10.68M12.77-$28.57M-$1.12-4.05CeriBell$65.44M9.30N/AN/AN/A Does the media prefer PROF or CBLL? In the previous week, CeriBell had 7 more articles in the media than Profound Medical. MarketBeat recorded 12 mentions for CeriBell and 5 mentions for Profound Medical. CeriBell's average media sentiment score of 0.23 beat Profound Medical's score of 0.16 indicating that CeriBell is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Profound Medical 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral CeriBell 2 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Is PROF or CBLL more profitable? CeriBell has a net margin of 0.00% compared to Profound Medical's net margin of -349.41%. CeriBell's return on equity of 0.00% beat Profound Medical's return on equity.Company Net Margins Return on Equity Return on Assets Profound Medical-349.41% -85.22% -64.87% CeriBell N/A N/A N/A Does the MarketBeat Community favor PROF or CBLL? Profound Medical received 30 more outperform votes than CeriBell when rated by MarketBeat users. However, 100.00% of users gave CeriBell an outperform vote while only 72.73% of users gave Profound Medical an outperform vote. CompanyUnderperformOutperformProfound MedicalOutperform Votes4072.73% Underperform Votes1527.27% CeriBellOutperform Votes10100.00% Underperform VotesNo Votes Do insiders & institutionals have more ownership in PROF or CBLL? 47.9% of Profound Medical shares are owned by institutional investors. 1.5% of Profound Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Do analysts prefer PROF or CBLL? Profound Medical currently has a consensus target price of $14.25, indicating a potential upside of 213.88%. CeriBell has a consensus target price of $32.50, indicating a potential upside of 91.51%. Given Profound Medical's stronger consensus rating and higher possible upside, analysts plainly believe Profound Medical is more favorable than CeriBell.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Profound Medical 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33CeriBell 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryCeriBell beats Profound Medical on 8 of the 15 factors compared between the two stocks. Remove Ads Get Profound Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for PROF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PROF vs. The Competition Export to ExcelMetricProfound MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$136.38M$3.88B$5.08B$6.91BDividend YieldN/A44.80%5.33%4.20%P/E Ratio-3.3926.5021.3317.05Price / Sales12.7742.89349.5885.95Price / CashN/A51.0838.1534.64Price / Book3.555.496.053.66Net Income-$28.57M$66.64M$3.19B$247.27M7 Day Performance-22.39%-10.40%-7.80%-8.86%1 Month Performance-33.82%-12.30%-6.79%-12.84%1 Year Performance-44.77%4.38%0.32%-10.80% Profound Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PROFProfound Medical1.9209 of 5 stars$4.54-3.2%$14.25+213.9%-44.8%$136.38M$10.68M-3.39150High Trading VolumeCBLLCeriBellN/A$19.21-1.3%$32.60+69.7%N/A$689.02M$65.44M0.00N/ALockup ExpirationNews CoverageIRMDIradimed4.7256 of 5 stars$52.48+0.1%$72.00+37.2%+15.1%$667.28M$73.24M34.99110News CoveragePositive NewsAVNSAvanos Medical2.7992 of 5 stars$14.34+2.8%N/A-36.6%$659.45M$687.80M42.164,040Gap UpKIDSOrthoPediatrics4.1198 of 5 stars$24.63-0.4%$37.25+51.2%-21.9%$598.19M$204.73M-20.02200Analyst ForecastNews CoveragePositive NewsSIBNSI-BONE3.7631 of 5 stars$14.03-0.1%$24.40+73.9%-14.8%$595.62M$167.18M-15.25350News CoveragePositive NewsBFLYButterfly Network2.3105 of 5 stars$2.27-4.4%$3.00+32.4%+110.0%$550.46M$82.06M-4.93460Gap DownBBNXBeta BionicsN/A$12.24+4.5%$24.83+102.9%N/A$530.59M$65.12M0.00294TMCITreace Medical Concepts3.0001 of 5 stars$8.39-0.7%$10.14+20.9%-42.0%$525.37M$209.36M-8.47250Positive NewsGap DownDCTHDelcath Systems2.8956 of 5 stars$12.73-3.2%$22.75+78.7%+106.2%$425.22M$37.21M-9.4360News CoveragePositive NewsHigh Trading VolumeNPCENeuroPace2.9374 of 5 stars$12.29+3.7%$15.20+23.7%-27.6%$400.16M$79.91M-12.29170Analyst RevisionNews CoverageGap Down Remove Ads Related Companies and Tools Related Companies CBLL Competitors IRMD Competitors AVNS Competitors KIDS Competitors SIBN Competitors BFLY Competitors BBNX Competitors TMCI Competitors DCTH Competitors NPCE Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PROF) was last updated on 4/9/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredElon’s Silver Play? Trump Clears the PathNothing is confirmed—yet. But Musk has disrupted every industry he's touched, and Trump's policies make the ti...Priority Gold | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Profound Medical Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Profound Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
